These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23811842)

  • 1. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.
    Limbruno U; Picchi A; Micheli A; Calabria P; Cortese B; Brizi G; Severi S; De Caterina R
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):587-94. PubMed ID: 23811842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
    Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
    Möckel M; Radovic M; Kühnle Y; Combé V; Waigand J; Schröder S; Dietz R; Frei U; Eckardt KU
    Nephrol Dial Transplant; 2008 May; 23(5):1588-94. PubMed ID: 18175785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
    Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
    Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-procedural bioimpedance vectorial analysis of fluid status and prediction of contrast-induced acute kidney injury.
    Maioli M; Toso A; Leoncini M; Musilli N; Bellandi F; Rosner MH; McCullough PA; Ronco C
    J Am Coll Cardiol; 2014 Apr; 63(14):1387-94. PubMed ID: 24530668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media.
    Azzalini L; Vilca LM; Lombardo F; Poletti E; Laricchia A; Beneduce A; Maccagni D; Demir OM; Slavich M; Giannini F; Carlino M; Margonato A; Cappelletti A; Colombo A
    Int J Cardiol; 2018 Dec; 273():69-73. PubMed ID: 30196995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
    Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
    Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
    Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of iodixanol versus iopamidol in patients undergoing peripheral angiography with or without endovascular therapy.
    Xiong HL; Peng M; Jiang XJ; Dong H; Che WQ; Chen Y; Zou YB; Xu B; Yang YJ; Gao RL
    Int Urol Nephrol; 2018 Oct; 50(10):1879-1886. PubMed ID: 29948863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxic effects in high-risk patients undergoing angiography.
    Aspelin P; Aubry P; Fransson SG; Strasser R; Willenbrock R; Berg KJ;
    N Engl J Med; 2003 Feb; 348(6):491-9. PubMed ID: 12571256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.
    Alexopoulos E; Spargias K; Kyrzopoulos S; Manginas A; Pavlides G; Voudris V; Lerakis S; McLean DS; Cokkinos DV
    Am J Med Sci; 2010 Jan; 339(1):25-30. PubMed ID: 19996728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
    Song T; Song M; Ge Z; Li Y; Shi P; Sun M
    J Interv Cardiol; 2017 Jun; 30(3):281-285. PubMed ID: 28421628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.